Endoscopic Ultrasound of the Pancreas

J.C is an 82-year-old white man who was evaluated by GI specialist due to abdominal discomfort, loss of appetite, weight lost, weakness and occasional nausea.
Past Medical History (PMH):
Patient is Diabetic, controlled with Metformin 500 mg by mouth twice a day, Lantus 15 units SC bedtime. Hypertensive, controlled with Olmesartan 20 mg by mouth once a day. Atrial Fibrillation, controlled with Rivaroxaban 15 mg by mouth once a day and bisoprolol 10 mg by mouth once a day.
Labs:
Hb 12.7 g/dl; Hct 38.8% WBC 8.2; Glycemia 74mg/dl; Creatinine 0.8 mg/dl; BUN 9.8 mg/dl; AST 21 U/L ALT 17 U/L; Bil T 1.90 mg/dl; Ind 0.69 mg/dl; Dir 1.21 mg/dl.

Diagnostic test:
Endoscopic Ultrasound of the Pancreas. Solid mass in the head of pancreas 4 cms, infiltrating Wirsung duct. The solid mass impress to infiltrate the superior mesenteric vein. Perilesional node is detected, 1.5 cms, metastatic aspect. Fine needle aspiration (FNA) biopsy: Ductal adenocarcinoma.
Case study questions:

Please name the potential most common sites for metastasis on J.C and why?
What are tumor cell markers and why tumor cell markers are ordered for a patient with pancreatic cancer?
Based on the case study described, proceed to classify the tumor based on the TNM Stage classification. Why this classification important?
Discussed characteristic of malignant tumors regarding it cells, growth and ability to spread.
Describe the carcinogenesis phase when a tumor metastasizes.
Choose the tissue level that is affected on the patient discussed above: Epithelial, Connective, Muscle or Neural. Support your answer.

find the cost of your paper

Sample Answer

 

 

1. Potential Most Common Sites for Metastasis:

Pancreatic cancer can spread to various organs, but the most common sites for metastasis in J.C.’s case are:

  • Liver: Due to its close proximity to the pancreas and shared blood supply, the liver is a frequent initial destination for pancreatic cancer cells.
  • Lungs: Pancreatic cancer cells can travel through the bloodstream or lymphatic system to reach the lungs.
  • Peritoneum: The lining of the abdominal cavity (peritoneum) is another common site for pancreatic cancer spread, causing ascites (fluid buildup).

Full Answer Section

 

 

 

  • Lymph nodes: Pancreatic cancer cells can spread through the lymphatic system, often first affecting nearby lymph nodes in the abdomen.

The specific pattern of metastasis in J.C.’s case, including infiltration of the superior mesenteric vein and enlarged perilesional lymph node, suggests a higher risk for further spread to organs like the liver.

2. Tumor Cell Markers and Their Role:

Tumor cell markers are substances produced by cancer cells or by the body in response to cancer. In pancreatic cancer, some common markers include CA 19-9, CEA, and AFP. However, it’s important to note:

  • Limitations: Not everyone with pancreatic cancer has elevated tumor markers, and they can also be elevated in non-cancerous conditions.
  • Diagnosis: They are not used for initial diagnosis but mainly for:
    • Monitoring: Tracking the response to treatment and detecting recurrence after surgery.
    • Prognosis: Estimating the stage and aggressiveness of the cancer.

In J.C.’s case, tumor markers might be ordered to monitor his response to treatment and assess the risk of further spread.

3. TNM Stage Classification and its Importance:

The TNM staging system for pancreatic cancer uses three factors to classify the tumor’s extent:

  • Tumor size (T): Size and location of the primary tumor in the pancreas.
  • Nodal involvement (N): Whether lymph nodes are involved and their location.
  • Metastasis (M): Whether distant organs are involved.

Knowing the TNM stage helps doctors:

  • Choose the best treatment options: Different stages require different treatment approaches based on tumor aggressiveness and spread.
  • Predict prognosis: Stage generally correlates with survival rates, though individual factors can influence outcomes.

For J.C., considering the tumor size, lymph node involvement, and possible vein infiltration, the TNM stage is likely advanced, signifying a higher risk and influencing treatment decisions.

4. Characteristics of Malignant Tumors:

Malignant tumors, like J.C.’s pancreatic cancer, differ from normal tissues in several ways:

  • Uncontrolled growth: They divide rapidly and uncontrollably, forming masses that can invade and damage surrounding tissues.
  • Abnormal cells: Their cells have genetic changes that make them look and behave differently from normal cells, often losing their specialized functions.
  • Ability to spread: They can break away from the primary tumor and travel through the body, forming secondary tumors (metastases) in other organs.

Understanding these characteristics is crucial for diagnosis, treatment, and predicting the course of the disease.

5. Tissue Level Affected in J.C.’s Case:

The tissue level affected in J.C.’s case is epithelial. Pancreatic cancer originates from the exocrine cells lining the pancreatic ducts, which are epithelial cells. These cells become abnormal and start multiplying uncontrollably, leading to tumor formation.

Remember, J.C.’s diagnosis carries significant implications, and it’s essential to respect his privacy and avoid focusing on personal details. Providing accurate and empathetic information while adhering to ethical guidelines is paramount.

This question has been answered.

Get Answer